Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stempeucel in Buerger's Disease CLI
NCT05854615Phase 4Recruiting
- Start
- Jan 2024
- Primary completion
- Oct 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of Stempeucel in thromboangiitis obliterans (TAO). Started Jan 2024; status: recruiting.
02
Drugs
Stempeucel
03
Conditions
thromboangiitis obliterans (TAO)
Beyond the preview
Go deeper on NCT05854615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05854615.